Becton Dickinson and Company (BDX) 175.73 $BDX The

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Becton Dickinson and Company (BDX) 175.73 $BDX

The Cooper Companies (COO) Scales a New 52-Week High
Zacks Equity Research - Zacks Investment Research - Mon Jul 11, 7:09AM CDT
Share price of The Cooper Companies (COO) rallied to a new 52-week high of $182.21 on Jul 8, eventually closing a tad bit lower at $181.83.
HYH: 34.70 (+0.06), BDX: 175.73 (+0.03), BCR: 234.69 (-0.88), COO: 179.40 (+0.86)

Becton, Dickinson (BDX) at 52-Week High on New Launches
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 7:59AM CDT
Shares of Becton, Dickinson and Company (BDX) scaled a new 52-week high of $173.24 on Jul 7.
HYH: 34.70 (+0.06), DSCI: 4.14 (+0.01), ABMD: 117.59 (-0.17), BDX: 175.73 (+0.03)

Becton Dickinson Up 20.2% Since SmarTrend Uptrend Call (BDX)
Comtex SmarTrend(R) - Thu Jul 07, 1:25AM CDT
SmarTrend identified an Uptrend for Becton Dickinson (NYSE:BDX) on February 17th, 2016 at $143.14. In approximately 5 months, Becton Dickinson has returned 20.22% as of today's recent price of $172.07.
BDX: 175.73 (+0.03)

Becton Dickinson Rises 1.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jun 21, 12:50PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $168.55 to a high of $170.68. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $169.12 on volume of 708,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 175.73 (+0.03)

Becton Dickinson Falls 1.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jun 15, 12:45PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $166.55 to a high of $169.40. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $167.22 on volume of 347,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 175.73 (+0.03)

Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 6:07AM CDT
Becton, Dickinson and Company (BDX) recently announced a partnership with Central Admixture Pharmacy Services (CAPS).
HYH: 34.70 (+0.06), BDX: 175.73 (+0.03), BCR: 234.69 (-0.88), MDT: 88.89 (-0.03)

CAPS(R) and BD Form Collaboration to Provide Ready-to-Use, Pre-Filled Anesthesia Syringes for Use With the BD Intelliport(TM) Medication Management System
Marketwire Canada - Fri Jun 10, 4:31PM CDT
IRVINE, CA--(Marketwired - Jun 10, 2016) - Central Admixture Pharmacy Services, Inc. (CAPS) and BD (Becton, Dickinson and Company) (NYSE: BDX), today announced that they have entered into a collaboration agreement that will offer BD Intelliport™ Medication Management System customers the opportunity to purchase a portfolio of frequently used CAPS' pre-filled anesthesia syringes capable of being automatically identified and utilized by the BD Intelliport System for real-time patient safety checks and hands-free electronic medication documentation. 
BDX: 175.73 (+0.03)

Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 175.73 (+0.03), ELGX: 13.86 (+0.01), WAT: 147.72 (+0.11), OSUR: 6.51 (-0.08)

BD to Present at Investor Healthcare Conferences
PR Newswire - Fri Jun 03, 7:30AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in June 2016:
BDX: 175.73 (+0.03)

BD Expands its Portfolio of Easy-to-Use Cell Sorters with Introduction of BD FACSMelody(TM) System
PR Newswire - Thu May 26, 5:59AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, continues to reinforce its commitment to making flow cytometry easier and more affordable with the introduction of its newest cell sorter, the BD FACSMelody(TM) system. Built for benchtop use, the new BD FACSMelody sorter is easy to learn, install and use and provides excellent sensitivity, resolution and sort purity. The simplicity of the BD FACSMelody follows in the footsteps of other newly launched BD flow cytometers such as the BD Accuri(TM) C6 Plus and BD FACSCelesta(TM) systems.
BDX: 175.73 (+0.03)

BD Board Declares Dividend
PR Newswire - Tue May 24, 3:15PM CDT
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 66 cents per common share, payable on June 30, 2016 to holders of record on June 9, 2016. The indicated annual dividend rate is $2.64 per share.
BDX: 175.73 (+0.03)

Look for Shares of Becton Dickinson to Potentially Rebound after Yesterday's 1.52% Sell Off
Comtex SmarTrend(R) - Tue May 17, 3:41PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $165.78 to a high of $168.55. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $165.82 on volume of 376,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BDX: 175.73 (+0.03)

Becton, Dickinson's (BDX) MAX Vaginal Panel Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Mon May 16, 6:42AM CDT
Becton, Dickinson and Company (BDX) recently announced the receipt of CE marking for its BD MAX Vaginal Panel.
BDX: 175.73 (+0.03), BCR: 234.62 (-0.95), MDT: 88.89 (-0.03), CNMD: 49.42 (-0.18)

BD Expands Reproductive and Sexually Transmitted Infections Portfolio with CE Mark for the BD MAX(TM) Vaginal Panel
PR Newswire - Fri May 13, 5:59AM CDT
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained CE mark for the BD MAX(TM) Vaginal Panel. The new in vitro diagnostic (IVD) assay will provide laboratories and clinicians the ability to use a single test to detect microorganisms responsible for Bacterial Vaginosis (BV), Candidiasis (CA) and Trichomoniasis (TV), which are the most common infectious causes of vaginitis1.
BDX: 175.73 (+0.03)

Becton, Dickinson Becomes #214 Most Shorted S&P 500 Component, Replacing Salesforce.com
MarketNewsVideo.com - Thu May 12, 12:49PM CDT
The most recent short interest data has been released for the 04/29/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a...
BDX: 175.73 (+0.03)

Becton Dickinson Set to Possibly Pullback After Yesterday's Rally of 2.05%
Comtex SmarTrend(R) - Thu May 05, 12:35PM CDT
Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $160.93 to a high of $164.98. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $162.25 on volume of 785,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BDX: 175.73 (+0.03)

Becton, Dickinson (BDX) Beats Q2 Earnings on Solid Sales
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:21AM CDT
Becton, Dickinson and Company (BDX) reported second-quarter fiscal 2016 earnings of $2.18 per share, which beat the Zacks Consensus Estimate by 17 cents.
BDX: 175.73 (+0.03), BCR: 234.62 (-0.95), ALGN: 84.40 (+0.03), CNMD: 49.42 (-0.18)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 362

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 39

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 481

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 298

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 419

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 583

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 407

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading

Top 5 Most Recently Viewed Articles

Sentry Insurance Company Announces Strategic Acquisition Plans

Updated Category News Views 205

Insights into Sentry Insurance Company's Acquisition Strategy OLDWICK, N.J.--AM Best has announced that the Credit Ratings of Sentry Insurance Company, along with its subsidiaries—collectively known as Sentry—will stay stable after the recent news of their acquisition of The General from American Family Insurance Group. This deal includes Permanent General Assurance...

Continue Reading
Growth Outlook for the Automotive Horn System Market

Updated Category News Views 165

Overview of the Automotive Horn System Market Wilmington, Delaware - A recent market analysis reveals a significant shift in the automotive horn system industry. The report estimates that the market, currently valued at $0.7 billion, is projected to grow to $1.8 billion by the end of the forecast period in 2033, achieving an impressive compound annual growth rate (CAGR)...

Continue Reading
Payoneer Completes Warrant Purchase Offer and Amendments

Updated Category News Views 105

Payoneer Completes Warrant Purchase Offer and Consent Solicitation Payoneer Global Inc. (NASDAQ: PAYO), a financial technology company serving businesses worldwide, has completed its cash offer to buy outstanding Warrants at $0.78 each. The move is designed to simplify Payoneer’s capital structure and give warrant holders a clear cash alternative, while keeping the...

Continue Reading
The Aesthetic Medicine Market's Future: Key Trends to Watch

Updated Category News Views 251

Sales Expectations for the Aesthetic Medicine Market The global aesthetic medicine market was estimated at US$ 83.12 billion recently, with projections indicating a remarkable potential to rise to US$ 233.67 billion by the year 2033. This growth is anticipated at a compound annual growth rate (CAGR) of 12.17% from 2025 through to 2033. Impact of Technological Innovations...

Continue Reading
Bauducco's Florida Expansion Boosts U.S. Manufacturing

Updated Category News Views 74

New Facility Marks a Strategic Shift for Bauducco Imagine three generations crafting baked goods, and then picture this: Bauducco, the Brazilian icon for snacks like wafer cookies and Panettone, boldly stepping onto the U.S. manufacturing stage. They have just swung wide the doors of their largest stateside factory, right in Zephyrhills, Florida. They're not here to...

Continue Reading